Non‐muscle‐invasive bladder cancerSince the turn of the 20th century Bacillus Calmette-Guerin (BCG) treatment for non-muscle invasive bladder cancer (NMIBC) has been in and out of favour. However, only a small proportion of patients, as low as 16%, complete what is seen as a gold ...
3.Zhiyong Li, Zhuowei Liu, et al.Preliminary results from a phase II study of tislelizumab combined with radiotherapy as bladder-preserving treatment for patients with high-risk non-muscle-invasive bladder cancer (HR NMIBC) unresponsive to bacillus Calmette-Guerin (BCG).2023ASCO GU. Abstract 51...
3.Zhiyong Li, Zhuowei Liu, et al.Preliminary results from a phase II study of tislelizumab combined with radiotherapy as bladder-preserving treatment for patients with high-risk non-muscle-invasive bladder cancer (HR NMIBC) unresponsive to bacillus Calmette-Guerin (BCG).2023ASCO GU. Abstract 51...
To our knowledge, this is the first report on BCG intravesical instillation therapy-induced urothelium necrosis of both the bladder and upper urinary tract. Although there were no obvious recurrences, surgical treatment alleviated severe sympto...
E16600- Interim results from a phase II study of tislelizumab combined with radiotherapy as bladder-preserving treatment for patients with high-risk non-muscle-invasive bladder cancer (HR NMIBC) unresponsive to bacillus Calm...
Table 1. Clinical Outcomes for Nonmuscle-invasive Bladder Cancer Patients Following Bacillus Calmette-Guerin Failure Treated With Commercially Available Treatment Agents 表1. 卡介苗治疗失败后非肌层浸润性膀胱癌患者接受已上市治疗药物的临床结局 ...
-a treatment that controlssuperficial bladder cancer, particularlycarcinoma in situ. I was surprised tolearn that an ancient vaccine, originallydesigned to prevent tuberculosis (TB), isemployed for a completely unrelatedindication and is the current treatment ofchoice for bladder cancer. I thought that...
目的:探讨卡介苗膀胱灌注对保留膀胱术后反复复发的膀胱移行细胞癌患者预防复发和进展的疗效。方法:对3例膀胱癌患者进行卡介苗灌注治疗的临床资料进行回顾性分析。结果:3例患者保留膀胱术后经卡介苗膀胱灌注治疗,复发率明显降低,进展减缓。结论:卡介苗膀胱灌注能够有效
Findings In this cohort study of 6467 patients with non–muscle-invasive bladder cancer, treatment with intravesical BCG vaccine was associated with a reduced risk of ADRD in the presence of death as a competing risk. However, the risk differences varied with time. Meaning The findings of this...
First-in-human Intravesical Delivery of Pembrolizumab Identifies Immune Activation in Bladder Cancer Unresponsive to Bacillus Calmette-Guérin 首次在人体内膀胱内给予派姆单抗识别出对卡介苗无反应的膀胱癌的免疫激活情况 Introduction 介绍 Treatm...